Aptose Biosciences (APTO)
(Delayed Data from NSDQ)
$0.92 USD
-0.02 (-2.09%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $0.90 -0.02 (-2.17%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Aptose Biosciences, Inc. [APTO]
Reports for Purchase
Showing records 81 - 100 ( 144 total )
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
2017 Results; The Building Potential Energy Is Electrifying for CG''806 and APTO-253; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
BET Program Finds a Home as All Eyes Remain Transfixed on CG''806
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
CG''806 Profile Points to the Phoenix Likely Rising; Hitting All the Right Baskets of Targets; Target Upped to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
3Q17 Results; Expecting Improving Product Profiles at ASH
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Cash Runway Extended; Blocking and Tackling Continues for ''806 and ''253; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Fall Two Times, Stand Up Three; Resuming with Buy and $5 PT
Provider: Roth Capital Partners, Inc.
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
The Brave New World of AML
Provider: Roth Capital Partners, Inc.
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Time to Make the Call as Inflection Points Near; Upgrade to Buy; Target Increased to $4
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Aptose Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
2Q17 Results; ''806 Synthesis Protocol Established; Oral Formulation Complete; Time for the Clinic
Provider: Rodman & Renshaw, Co.